Putting Patients First Blog

MARCH 4, 2024

However, we urge CMS to consider the following recommendations to ensure the 2025 policies further align with patient-centered care. The NHC recommends clear communication to beneficiaries about these changes and robust support systems to address any issues that may arise during the transition.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Communication Hospitals 40

Putting Patients First Blog

MARCH 18, 2024

The NHC supports the development and use of processes and tools that enhance beneficiary experience, making interactions with the MPPP smoother and more intuitive for all beneficiaries. It is vital that communication, both for beneficiaries and for health care providers and pharmacists, adhere to these principles.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Communication Documentation Mail-Order Pharmacies 40

Putting Patients First Blog

MARCH 18, 2024

The NHC supports the development and use of processes and tools that enhance beneficiary experience, making interactions with the MPPP smoother and more intuitive for all beneficiaries. It is vital that communication, both for beneficiaries and for health care providers and pharmacists, adhere to these principles.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Communication Documentation Mail-Order Pharmacies 40

Putting Patients First Blog

JUNE 5, 2023

This is not a venue that patients and their advocates have access to, as health insurance plans are the primary users of the portal. CMS must ensure stakeholders have ample opportunity to provide input throughout the implementation and adjustment process. A simple 30-day comment period process will likely not be sufficient.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Communication 40

Putting Patients First Blog

JANUARY 27, 2025

Coverage of Anti-Obesity Medications (AOMs) The NHC applauds CMS for aligning with the medical community and proposing to recognize obesity as a chronic disease and allow Medicare Part D coverage for AOMs. Below, we provide detailed comments and recommendations on key provisions of the proposed rule.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Biosimilars Communication Department of Veterans Affairs 40

Putting Patients First Blog

MAY 29, 2024

1 This trend underscores the importance of informed decision-making for those with chronic diseases and disabilities, who face crucial choices regarding their health care coverage – whether selecting between traditional Medicare and MA, choosing among MA plans, or navigating their selected plan to access necessary care. As of 2023, 30.8

Insurance Coverage and Processing 52

Insurance Coverage and Processing Communication Prescription Filling Hospitals 52

Pharmaceutical Technology

JUNE 16, 2025

June 16, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Ethris’ platform technologies have shown favourable results in Phase I trials for ETH47. These platforms are designed for safe drug production while allowing scaleable manufacturing processes. Credit: Cryptographer/Shutterstock.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Vaccines Communication Hospitals 52

Putting Patients First Blog

NOVEMBER 12, 2024

General Support for CMS Proposals The NHC commends CMS for its ongoing commitment to advancing health equity, improving access to care, ensuring program integrity, and maintaining affordability through Marketplace coverage. Copay Assistance and Drug Coverage in Large Group Plans Accumulator Adjustment Programs and Cost Sharing.

Insurance Coverage and Processing 52

Insurance Coverage and Processing HIV Treatment and Prevention Agents Communication Hospitals 52

Putting Patients First Blog

SEPTEMBER 9, 2024

16 We encourage CMS to continue refining these data collection processes to ensure they capture meaningful and actionable information. We believe this process is crucial for adapting the payment system to evolving clinical practices and emerging medical technologies.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Hospitals Inpatient Documentation 40

Pharmaceutical Technology

JUNE 16, 2025

Robert Barrie June 16, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Elevidys is the only gene therapy approved in US for DMD. The first death due to ALF, announced in March 2025, prompted the suspension of multiple clinical trials evaluating the gene therapy in different patient populations with DMD.

Insurance Coverage and Processing 98

Insurance Coverage and Processing Communication Hospitals Vaccines 98

Putting Patients First Blog

SEPTEMBER 9, 2024

CY 2025 PFS proposed rule). The continuation of audio-only communication options remains essential. As these technologies become increasingly integral to patient care, it is essential for CMS to develop clear and consistent guidelines for the payment and coverage of AI-enabled services.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Documentation Vaccines Communication 40

Pharmaceutical Technology

JUNE 13, 2025

Robert Barrie June 13, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook mRESVIA is the second approved product in the US for Moderna, along with its Covid-19 vaccine Spikevax. mRNA vaccine coverage on Pharmaceutical Technology (or Clinical Trials Arena) is supported by Trilink.

Vaccines 52

Vaccines Insurance Coverage and Processing Labelling Communication 52

Putting Patients First Blog

FEBRUARY 11, 2025

3 Establishing a feedback loop with stakeholders during this monitoring process will provide additional safeguards against adverse effects. Engaging stakeholders in transparent decision-making processes is critical to the success of risk adjustment model updates.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Communication Documentation Hospitals 52

Pharmaceutical Technology

JUNE 10, 2025

Robert Barrie and Ross Law June 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The removal ACIP members marks the most significant upheaval to the current vaccine landscape under Trump’s administration. lev radin via Shutterstock.

Vaccines 52

Vaccines Insurance Coverage and Processing Drug Pricing Immunity 52